|p/b ratio better than 1.57 or less (better than 3 divided by number =mean)|
|Per Share (mrq):|
|United Microelectronics Corp||UMC||2.79||0.68|
|Anworth Mortgage Asset Corp||ANH||7.16||0.87|
|Annaly Capital Management Inc||NLY||15.85||0.98|
|Hatteras Financial Corp||HTS||28.28||0.99|
|Invesco Mortgage Capital Inc||IVR||20.85||1.04|
|Minnesota Municipal Income Portfolio||MXA||16.16||1.1|
|Royal Dutch Shell PLC||RDS.A||59.78||1.11|
|New York Mortgage Trust Inc||NYMT||6.5||1.14|
Rosneft closes $55bn TNK-BP deal
By Guy Chazan
Russian oil company Rosneft announced on Thursday it had closed the $55bn deal to acquire TNK-BP, making it the world's largest publicly traded oil producer. In a statement, Rosneft said it had finalised a deal to acquire the 50 per cent share of TNK-BP owned by AAR, a consortium of...
|14:50 GMT||Mar 21 2013||BP:NYQ|
Lululemon bent out of shape over pants recall
By Barney Jopson in New York
Lululemon Athletica, the sportswear brand in crisis over see-through yoga pants, acknowledged that it did not test how its products looked when wearers bent over before shipping millions of pairs that it has been forced to recall. Christine Day, Lululemon's chief executive, said the product had passed all initial testing,...
|14:37 GMT||Mar 21 2013||LULU:NSQ|
AstraZeneca to cut 5,000 jobs by 2016
By Andrew Jack in London
AstraZeneca is to cut a tenth of its workforce over the next three years and refocus its research away from medicines to treat infections and in efforts to boost its flagging growth. The beleaguered Anglo-Swedish pharmaceutical group announced a $2.3bn charge to cover costs of reducing its headcount by more...
|08:30 GMT||Mar 21 2013||AZN:NYQ|
Person of the year: Scale the heights
By Javier Blas
When Ivan Glasenberg sat down in September with Sheikh Hamad bin Jassim bin Jabr al-Thani, Qatar's prime minister, the Glencore chief executive's aim was clear: seal the deal to buy Xstrata. Glasenberg had claimed he was ready to walk away from the transaction if HBJ - as Sheikh Hamad is...
|00:03 GMT||Mar 21 2013||BP:NYQ, CVX:NYQ|
BP stays out of bidding for gulf drilling
By Ed Crooks in New York
BP decided not to bid for new drilling rights in the Gulf of Mexico on Wednesday because of uncertainty over the US government's ban on it signing new contracts. The Bureau of Ocean Energy Management, which handles offshore drilling rights, said last week that BP would be allowed to bid...
|23:25 GMT||Mar 20 2013||BP:NYQ|
Energy groups form shale gas alliance
By Ed Crooks in New York
Royal Dutch Shell, Chevron and Consol Energy have formed a new alliance with groups including the Environmental Defense Fund and the Clean Air Task Force to set performance standards for shale gas production, in a bid to address public concerns about the controversial practice. The Center for Sustainable Shale Development...
|22:59 GMT||Mar 20 2013||RDS.A:NYQ, CVX:NYQ|
Walgreens: empire building
How hard can it be to move a bunch of pills around? Hard. Pharma distribution is a big business because the inventory is expensive, comes in zillions of varieties, and retailers can't afford to be caught short. The three major US drug distributors - McKesson, Cardinal, and AmerisourceBergen - have...
|18:30 GMT||Mar 20 2013||WAG:NYQ|
Batista struggles to win over investors
By Samantha Pearson in São Paulo
In his autobiography the Brazilian billionaire Eike Batista praises his two most important business partners: Brazil and the market. "I could have easily chosen other countries to base my companies," writes the former speedboat racing champion. "I see myself as one of Brazil's soldiers." But while Latin America's largest economy...
|18:06 GMT||Mar 20 2013||BP:NYQ|
Manufacturing wins over climate change levy exemptions
By Pilita Clark, Environment Correspondent
Steelmakers and pottery companies have had a boost in a Budget that has exempted some of their manufacturing processes from a contentious tax designed to encourage businesses to use energy more efficiently. "Creating a low carbon economy should be done in a way that creates jobs rather than costing them,"...
|15:19 GMT||Mar 20 2013||RDS.A:NYQ|
American Realty in $5.7bn bid for Cole Credit
By David Gelles in New York
American Realty Capital Properties made an unsolicited $5.7bn offer for Cole Credit Property Trust III on Wednesday, a move that would scuttle Cole Credit's bid to go public and sets up a complicated tussle between the two real estate investment trusts. American Realty already manages swaths of commercial space around...
|14:47 GMT||Mar 20 2013||WAG:NYQ|
Investors hit at India business climate
By Victor Mallet in New Delhi and James Crabtree in Mumbai
In the eyes of government ministers in New Delhi, India has in the past eight months embarked on a bold programme of liberalisation and economic reform in an effort to attract foreign investors and revive economic growth. "Doing business in India must be seen as easy, friendly and mutually beneficial,"...
|13:25 GMT||Mar 20 2013||NOK:NYQ, RDS.A:NYQ|
Chinese seek change as continuity rules
By Henny Sender
Conversation in the coffee shops of Palo Alto is starting to sound more like the talk in the milk tea shops of Hong Kong. It is all about Chinese money going into the property market and driving prices to record highs - though to be fair it is tech industry...
|17:28 GMT||Mar 19 2013||CEO:NYQ|
Cyprus levy concerns weigh on US stocks
By Anora Mahmudova in New York
Early gains on Wall Street fizzled out, as fears over imposing a levy on bank deposits in Cyprus overshadowed positive US housing data showing home construction rose in February. The benchmark S&P 500 index was trading marginally lower at 1,550.55, pulling away from near-record levels of last week. The Dow...
|15:13 GMT||Mar 19 2013||WAG:NYQ|
Defensive AstraZeneca punts on Cambridge
By Jonathan Guthrie
Karma is revenging itself on George Osborne. In last year's budget he trumpeted news that GlaxoSmithKline would spend £500m on a Cumbrian R&D hub as a vindication of the government's innovation policy. But his 2013 address on the state of the economy will come just after AstraZeneca announced it is...
|00:01 GMT||Mar 19 2013||AZN:NYQ|
Soriot's bitter pill for chancellor
By Andrew Jack
A Frenchman has given George Osborne a bitter pill to swallow on the eve of his Budget this week, with the decision by AstraZeneca to sharply cut back staff and investment at its historic Alderley Park medicines research centre in the chancellor's English constituency. For more than half a century,...
|23:06 GMT||Mar 18 2013||AZN:NYQ|